Vol. 14 Issue 2

EBM Tools for Practice: Keep Things Flowing Smoothly: The Evolving Role of Aspirin in Primary ASCVD Prevention

.color-blue{ color: #23527c; } Acetylsalicylic acid, or aspirin, has played a central role in the secondary prevention of cardiovascular disease (CVD) for decades, but the data for primary prevention is less clear. The current recommendations are conflicting. The U.S. Preventive Services Task... more

From the NLA President: Non-Statin Therapy for Atherogenic Cholesterol Reduction

As clinical lipidogists, the major objective of care for most of our patients is to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). All major guideline documents, including the NLA Recommendations for Patient-Centered Management of Dyslipidemia and the 2013 American College of... more

From the SELA President: Horses, Zebras, and Unicorns — Oh My!

The theme of this issue of LipidSpin is “Unusual Causes of Dyslipidemia/Less Common Dyslipidemias.” Topics range from sitosterolemia, to lysosomal acid lipase deficiency, to myositis due to red yeast rice. Although not necessarily rare for many lipidologists, other topics include potential... more

Letter From the LipidSpin Editor: There is Never a Dull Moment In the World of Clinical Lipidology

This edition of the LipidSpin is an outstanding representation of how there is never a dull moment in the world of clinical lipidology. This SELA edition of LipidSpin has many outstanding lessons and insights nested within the various articles. As I read through this edition, two things stand out... more